Literature DB >> 17180119

Enhancement of gene transfer to human myeloid cells by adenovirus-fiber complexes.

Ronald R Nepomuceno1, Lars Pache, Glen R Nemerow.   

Abstract

Adenoviral (Ad) vectors are currently being developed for immunotherapy and vaccine delivery, particularly for cancer and antiviral treatment (e.g., human immunodeficiency virus vaccine). However, the inefficient transduction of antigen-presenting cells of myeloid lineage such as dendritic cells (DCs) by conventional Ad5-based vectors limits these applications. DCs lack the coxsackie and adenovirus receptor but express CD46, a member of the family of complement regulatory proteins, as well as sialic acid glycoconjugates, a situation that allows infection by Ad type 37 as well as most subgroup B Ads. In this study, we generated recombinant Ad fiber knobs (FKs) to probe Ad37 receptor usage on immune cells. Remarkably, treatment of human myeloid cells with Ad37 FK (37FK) enhanced, rather than inhibited transduction by Ad5 or Ad37 pseudotyped virions. The enhanced gene transfer was dose dependent, involved association with alpha(2,6)-linked sialic acid residues, and was limited to blood cells of myeloid lineage, including immature and mature DCs. We also provide evidence that 37FK binds directly to Ad5 virus particles, likely acting as a bridge to facilitate greater virus-cell interaction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17180119     DOI: 10.1038/sj.mt.6300048

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  8 in total

1.  Structural variations in species B adenovirus fibers impact CD46 association.

Authors:  Lars Pache; Sangita Venkataraman; Vijay S Reddy; Glen R Nemerow
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

2.  Inhibition of adenovirus replication by a trisubstituted piperazin-2-one derivative.

Authors:  Javier Sanchez-Cespedes; Crystal L Moyer; Landon R Whitby; Dale L Boger; Glen R Nemerow
Journal:  Antiviral Res       Date:  2014-06-04       Impact factor: 5.970

3.  Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization.

Authors:  Jason G Smith; Mariena Silvestry; Steffen Lindert; Wuyuan Lu; Glen R Nemerow; Phoebe L Stewart
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

Review 4.  Insights into adenovirus host cell interactions from structural studies.

Authors:  G R Nemerow; L Pache; V Reddy; P L Stewart
Journal:  Virology       Date:  2008-11-20       Impact factor: 3.616

5.  Discovery of a Small Molecule Inhibitor of Human Adenovirus Capable of Preventing Escape from the Endosome.

Authors:  Jimin Xu; Judith Berastegui-Cabrera; Marta Carretero-Ledesma; Haiying Chen; Yu Xue; Eric A Wold; Jerónimo Pachón; Jia Zhou; Javier Sánchez-Céspedes
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

6.  Differential macrophage polarization promotes tissue remodeling and repair in a model of ischemic retinopathy.

Authors:  Valentina Marchetti; Oscar Yanes; Edith Aguilar; Matthew Wang; David Friedlander; Stacey Moreno; Kathleen Storm; Min Zhan; Samia Naccache; Glen Nemerow; Gary Siuzdak; Martin Friedlander
Journal:  Sci Rep       Date:  2011-08-30       Impact factor: 4.379

7.  Alpha-defensin-dependent enhancement of enteric viral infection.

Authors:  Sarah S Wilson; Beth A Bromme; Mayumi K Holly; Mayim E Wiens; Anshu P Gounder; Youngmee Sul; Jason G Smith
Journal:  PLoS Pathog       Date:  2017-06-16       Impact factor: 6.823

8.  Repositioning salicylanilide anthelmintic drugs to treat adenovirus infections.

Authors:  José A Marrugal-Lorenzo; Ana Serna-Gallego; Judith Berastegui-Cabrera; Jerónimo Pachón; Javier Sánchez-Céspedes
Journal:  Sci Rep       Date:  2019-01-09       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.